Kenji Sekiguchi

Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy

Jérôme Devaux, Yumako Miura, Yuki Fukami et al. · Neurology · 2016 · 271 citations · Full text

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

Vera Bril, Artur Drużdż, Julian Großkreutz et al. · The Lancet Neurology · 2023 · 227 citations

Clinical Trials, Generalised Myasthenia Gravis, Pharmacotherapy +3

Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies

Jean‐Michel Vallat, Nobuhiro Yuki, Kenji Sekiguchi et al. · Neuromuscular Disorders · 2016 · 103 citations · Full text

Autoimmune Disease, Ophthalmology, Scleroderma +13

Ultrasonographic diaphragm thickness correlates with compound muscle action potential amplitude and forced vital capacity

Yoshikatsu Noda, Kenji Sekiguchi, Nobuo Kohara et al. · Muscle & Nerve · 2015 · 75 citations

Intravenous immunoglobulin for maintenance treatment of chronic inflammatory demyelinating polyneuropathy: a multicentre, open-label, 52-week phase III trial

Satoshi Kuwabara, Masahiro Mori, Sonoko Misawa et al. · Journal of Neurology Neurosurgery & Psychiatry · 2017 · 52 citations · Full text